Irina Matsneva, MD

Dr Matsneva is a first-year psychiatry resident at Creighton University.

Articles by Irina Matsneva, MD

Evaluating Glucagon-Like Peptide-1 Receptor Agonists and Mental Health Outcomes

ByMasha Impallaria, MD,Caitlin Leconte, MD,Irina Matsneva, MD,Albert Dickan, MD,Haley Schuster, MD,Mark Mullen, MD,Rajesh R. Tampi, MD, MS, DFAPA, DFAAGP

May 11th 2026

Large meta-analysis finds GLP-1 drugs don’t raise depression or suicidality and modestly boost quality of life and eating control in diabetes/obesity.

Irina Matsneva, MD

Articles by Irina Matsneva, MD

Evaluating Glucagon-Like Peptide-1 Receptor Agonists and Mental Health Outcomes

Latest Updated Articles

Trending on Psychiatric Times

Positive Topline Results From Phase 3 Emerge Study of DT120 ODT in Major Depressive Disorder

FDA Issues CRL for Cytisinicline for Smoking Cessation in Adults